Medical News

RSS

White House leaning towards public option with state opt out provision, Sen. Nelson says

"Senate Majority Leader Harry Reid (D-Nev.) and the White House are leaning towards including a national public option -- with a provision for states to opt out of it -- in the Senate health care bill, Sen. Ben. Nelson (D-Neb.) said Thursday" after a briefing with Finance Committee Chairman Max Baucus (D-Mont.), Politico's Live Pulse blog reports.

23 Oct 2009

Twenty charged with Medicare fraud; and such crimes are emerging as a new area for gang activity

Federal authorities have charged 20 people with Medicare fraud in seven different cases. Those charged alledgedly bilked the government out of about $26 million in unneeded or undelivered medical equipment in California and Las Vegas.

23 Oct 2009

Most health professionals lack access to tests for diagnosing primary syphilis, reveals survey

Although syphilis is one of the oldest known diseases, most health professionals do not have access to the tests necessary to reliably diagnose it in its earliest and most infectious stage. A recent survey of infectious diseases specialists regarding the diagnosis and treatment of syphilis appears in the November 15, 2009 issue of Clinical Infectious Diseases, now available online.

23 Oct 2009

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.

23 Oct 2009

BNA launches Health IT Law & Industry Report

To help clarify and analyze the framework of regulation, compliance, and federal and state privacy laws that will govern the more than $30 billion in stimulus funding for health information technology (HIT), specialized news and information publisher BNA has launched the Health IT Law & Industry Report.

23 Oct 2009

Intellectual property covering compounds that have utility in treating SMA licensed

Repligen Corporation announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy (FSMA) for intellectual property covering compounds which may have utility in treating Spinal Muscular Atrophy (SMA).

23 Oct 2009

U.N. report documents how opium contributes to spread of disease, deaths

The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).

23 Oct 2009

Non-adherence to medication may be the cause for difficult asthma

Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.

23 Oct 2009

Aethlon Medical establishes ESI as a wholly owned subsidiary

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that it has established Exosome Sciences, Inc. (ESI) as a wholly owned subsidiary of the Company.

23 Oct 2009

CellAura to provide pharmacologically validated reagents for Cisbio Bioassays' cellular studies

CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays’ Tag-lite™ range of non-radioactive assays for cellular studies.

23 Oct 2009

New method devised for harvesting purified protein molecules

Drugs based on engineered proteins represent a new frontier for pharmaceutical makers. Even after they discover a protein that may form the basis of the next wonder drug, however, they have to confront a long-standing problem: how to produce large quantities of the protein in a highly pure state.

23 Oct 2009

Report: Quality of care for insured Americans slipped in 2008

CNNMoney reports that for the first time in more than 10 years, the "overall quality of health care" for Americans insured through commercial and public plans appears to have slipped.

23 Oct 2009

Lumetra awarded a Veterans Health Administration Protected Clinical Peer Review Services contract

Lumetra is pleased to announce that the Department of Veterans Affairs has awarded the California-based healthcare consulting organization a contract for Veterans Health Administration (VHA) Protected Clinical Peer Review Services. Effective on September 30, 2009, the contract is for a one-year period, with the VHA having the choice to exercise four option years.

23 Oct 2009

Large firms that 'self-insure' are resisting new regulations

"Despite promises by President Barack Obama, more than 70 million Americans who have health insurance through their jobs could be open to higher costs or denials of some coverage under a leading overhaul plan making its way through Congress," The Associated Press reports.

23 Oct 2009

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

Theravance, Inc. announced today that it has earned a milestone payment of $20 million for the U.S. Food and Drug Administration (FDA) approval of VIBATIV (telavancin) and supplying its collaboration partner, Astellas Pharma US, Inc. (Astellas), with the launch inventory for the first commercial sale in the United States.

23 Oct 2009

CLSI and Analyse-it Software to develop practice standards and guidelines for medical laboratories

Recognizing that robust statistical tools are essential for ensuring accurate results for increasingly advanced medical tests, Clinical and Laboratory Standards Institute (CLSI) and Analyse-it Software, Ltd. (Analyse-it®), are pleased to announce a new joint venture partnership to combine CLSI’s expertise in developing best practice standards and guidelines for the medical laboratory with the power of Analyse-it’s expertise in developing statistical software.

23 Oct 2009

American Thoracic Society releases new clinical guidelines for pulmonary exacerbation of cystic fibrosis

The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices.

23 Oct 2009

AJC urges Egyptian government to allow Israeli breast cancer researchers to enter the country

The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.

23 Oct 2009

Obama adopting a more partisan tone on health care

"In sharp contrast to how he got elected, President Barack Obama is bashing Republicans this week while urging Democrats to unite behind his effort to reform the nation's healthcare system," The Hill reports. "Months after some Democrats on and off Capitol Hill were suggesting that healthcare reform could attract 70 to 80 votes in the Senate, Obama and congressional leaders are focused on uniting their party and picking up, at most, a couple GOP defectors to help clear the 60-vote hurdle in the upper chamber."

23 Oct 2009

Senate Dems still debating public option in health bills

Senate Democratic leaders are tracking the support of a government-run public option in health care reform legislation.

23 Oct 2009

Medical News

White House leaning towards public option with state opt out provision, Sen. Nelson says

Twenty charged with Medicare fraud; and such crimes are emerging as a new area for gang activity

Most health professionals lack access to tests for diagnosing primary syphilis, reveals survey

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

BNA launches Health IT Law & Industry Report

Intellectual property covering compounds that have utility in treating SMA licensed

U.N. report documents how opium contributes to spread of disease, deaths

Non-adherence to medication may be the cause for difficult asthma

Aethlon Medical establishes ESI as a wholly owned subsidiary

CellAura to provide pharmacologically validated reagents for Cisbio Bioassays' cellular studies

New method devised for harvesting purified protein molecules

Report: Quality of care for insured Americans slipped in 2008

Lumetra awarded a Veterans Health Administration Protected Clinical Peer Review Services contract

Large firms that 'self-insure' are resisting new regulations

Theravance earns milestone payment for bactericidal, injectable lipoglycopeptide antibiotic

CLSI and Analyse-it Software to develop practice standards and guidelines for medical laboratories

American Thoracic Society releases new clinical guidelines for pulmonary exacerbation of cystic fibrosis

AJC urges Egyptian government to allow Israeli breast cancer researchers to enter the country

Obama adopting a more partisan tone on health care

Senate Dems still debating public option in health bills

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News